OAM
Oppenheimer Asset Management Portfolio holdings
AUM
$8.72B
1-Year Return
19.29%
This Quarter Return
+17.18%
1 Year Return
+19.29%
3 Year Return
+71.82%
5 Year Return
+126.54%
10 Year Return
+242.9%
AUM
$5.99B
AUM Growth
+$838M
(+16%)
Cap. Flow
+$87.8M
Cap. Flow
% of AUM
1.47%
Top 10 Holdings %
Top 10 Hldgs %
14.39%
Holding
1,189
New
99
Increased
492
Reduced
540
Closed
55
Top Buys
| 1 |
Unilever
UL
|
$19.2M |
| 2 |
Illumina
ILMN
|
$10.6M |
| 3 |
Chevron
CVX
|
$10.1M |
| 4 |
Morgan Stanley
MS
|
$8.53M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
$8.23M |
Top Sells
| 1 |
UN
Unilever NV New York Registry Shares
UN
|
$16.8M |
| 2 |
Amgen
AMGN
|
$6.1M |
| 3 |
Citigroup
C
|
$5.8M |
| 4 |
ETFC
E*Trade Financial Corporation
ETFC
|
$5.4M |
| 5 |
First Trust Managed Municipal ETF
FMB
|
$5.15M |
Sector Composition
| 1 | Technology | 20.78% |
| 2 | Financials | 14.29% |
| 3 | Healthcare | 13.91% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Phibro Animal Health
PAHC
$1.59B
| $283K | ﹤0.01% |
14,588
-151
| -1% | -$2.93K |
|
1002
Arcosa
ACA
$4.78B
| $281K | ﹤0.01% |
5,118
-1,322
| -21% | -$72.6K |
|
1003
Envista
NVST
$3.54B
| $281K | ﹤0.01% |
8,347
-1,897
| -19% | -$63.9K |
|
1004
Avanos Medical
AVNS
$586M
| $277K | ﹤0.01% |
6,038
-3,508
| -37% | -$161K |
|
1005
State Street
STT
$32B
| $275K | ﹤0.01% |
+3,770
| New | +$275K |
|
1006
PTC
PTC
$25.5B
| $273K | ﹤0.01% |
+2,278
| New | +$273K |
|
1007
Citi Trends
CTRN
$314M
| $272K | ﹤0.01% |
+5,478
| New | +$272K |
|
1008
Park Hotels & Resorts
PK
$2.39B
| $268K | ﹤0.01% |
+15,599
| New | +$268K |
|
1009
TransUnion
TRU
$17.6B
| $268K | ﹤0.01% |
2,700
-1,522
| -36% | -$151K |
|
1010
Enel Chile
ENIC
$5.1B
| $267K | ﹤0.01% |
68,509
-11,349
| -14% | -$44.2K |
|
1011
Lifecore Biomedical
LFCR
$283M
| $267K | ﹤0.01% |
24,576
+12,305
| +100% | +$134K |
|
|
PPD
1012
DELISTED
PPD, Inc. Common Stock
PPD
| $267K | ﹤0.01% |
7,815
-390
| -5% | -$13.3K |
|
1013
iShares Russell Mid-Cap Growth ETF
IWP
$20.4B
| $266K | ﹤0.01% |
+2,595
| New | +$266K |
|
|
EAR
1014
DELISTED
Eargo, Inc. Common Stock
EAR
| $264K | ﹤0.01% |
+295
| New | +$264K |
|
1015
CubeSmart
CUBE
$9.51B
| $263K | ﹤0.01% |
7,841
-3,011
| -28% | -$101K |
|
1016
Steven Madden
SHOO
$2.2B
| $263K | ﹤0.01% |
+7,442
| New | +$263K |
|
1017
Mercury Systems
MRCY
$4.1B
| $259K | ﹤0.01% |
2,939
-239
| -8% | -$21.1K |
|
|
BLUE
1018
DELISTED
bluebird bio
BLUE
| $258K | ﹤0.01% |
460
-42
| -8% | -$23.6K |
|
1019
Cardinal Health
CAH
$35.6B
| $256K | ﹤0.01% |
4,781
-640
| -12% | -$34.3K |
|
1020
Axalta
AXTA
$6.91B
| $253K | ﹤0.01% |
8,847
-257
| -3% | -$7.35K |
|
1021
Vontier
VNT
$6.36B
| $253K | ﹤0.01% |
+7,559
| New | +$253K |
|
1022
SPX Corp
SPXC
$9.28B
| $252K | ﹤0.01% |
4,619
+5
| +0.1% | +$273 |
|
1023
Vanguard Russell 2000 ETF
VTWO
$12.7B
| $252K | ﹤0.01% |
+3,186
| New | +$252K |
|
1024
Hologic
HOLX
$14.8B
| $251K | ﹤0.01% |
+3,434
| New | +$251K |
|
1025
Henry Schein
HSIC
$8.4B
| $251K | ﹤0.01% |
+3,747
| New | +$251K |
|